Market Snapshot

The oral thin film pharmaceuticals market size was worth USD 3.4 billion in 2022 and is expected to rise from USD 3.7 billion in 2023 to USD 7.38 billion by 2032, with a compound yearly growth rate (CAGR) of 9.01% during the forecast period (2023-2032).

Oral thin films (OTF) are loaded with active substance that are used for drug delivery via mouth. OTF drugs easily dissolve with saliva, therefore it is likely to gain traction, which can boost the oral thin film drugs market 2020. Further, the minimal invasive attribute of OTF drugs is projected to be another key market driving factor. These drugs are likely to have a high acceptance rate due to its ease of application and high efficiency, which can induce major market gains during the forecast period. In addition, the incessant technical development in OTF drugs is likely to boost its demand and develop the market.

On the contrary, the high cost of treatment is projected to obstruct the market growth during the review period. However, its clinical benefits and rising geriatric population are likely to combat hampering causes, and boost the demand for OTF drugs.

Market Segmentation

The segment analysis of the global oral thin film drugs market is done by disease indication, product, and distribution channel.

The diseases indication based segments of the global oral thin film drugs market are migraine, schizophrenia, opioid dependence, and nausea and vomiting, and others. Among these segments, the migraine segment is estimated to grow at a robust pace during the forecast period.

The product-based segments of the global oral thin film drugs market are Fast Dissolving Buccal Film and sublingual.

The distribution channel based segments of the global oral thin film drugs market are retail pharmacies, hospital pharmacies, online drug stores, and others. The retail pharmacies are likely to procure the valuation of USD 1 9309.9 million by 2023.

Regional Analysis

Based on the region, the global oral thin film drugs market is segmented into Europe, North America, Asia-Pacific, and the Middle East and Africa.

As per the research by MRFR, the OTF drugs market is likely to be led by the Americas during the forecast period owing to the presence of globally renowned players. Further, the developed healthcare sector with increased expenditure to avail medical facilities are projected to be other potent factors in market development in the region. The analysis reveals that the expansion of retail pharmacies in the region can assist the Americas in procuring the CAGR of 10.72% during the review period.

Europe is predicted to witness robust growth during the review period owing to the increased favorable initiatives taken by the government of various developed countries situated in the region. Further, rising healthcare funds are anticipated to drive the regional market significantly.

The APAC region is estimated to be a lucrative market during the forecast period owing to the presence of developing economies. The growing geriatric population in the region is estimated to play a crucial role in augmenting the regional market.

The MEA region is likely to experience slow growth due to the presence of sluggish economies, majorly in Africa. However, the well-developed countries like the UAE, Qatar, and others can make a significant contribution owing to sufficient healthcare budget.

Key Players

The renowned players of the global oral thin film drugs market research are Indivior Plc (U.S.), Novartis AG (Switzerland), LTS Lohmann Therapie-Systeme AG (Germany), CURE Pharmaceutical (U.S.), GlaxoSmithKline Plc (U.K.), Pfizer Inc. (U.S.), and Johnson & Johnson Services, Inc. (U.S.).

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com